Clinical trial
A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome
NCT00001839 is registered in ClinicalTrials.gov with National Institutes of Health Clinical Center (CC) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Trial of Antithymocyte Globulin Versus Cyclosporine to Treat the Cytopenia of Myelodysplastic Syndrome
- Lead sponsor
- National Institutes of Health Clinical Center (CC)
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- December 31, 1998
- Completion date
- May 31, 2000
- Enrollment
- 182
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.